journal article·2019-02

Determination of half maximal inhibitory concentration of CaAl layered double hydroxide on cancer cells and its role in the apoptotic pathway

Arnab Bhattacharjee, Sk Hasanur Rahaman, Suman Saha, Monisha Chakraborty, Jui Chakraborty

Publisher page

Abstract

Abstract In continuation of our previous work, which proposed a new direction of application of the bare, phase pure CaAl LDH as an active anticancer agent, the efficacy of the system was assessed by determination of half maximal inhibitory concentration (IC50) of the same on human colon cancer (HCT 116) cell line and human breast cancer (MCF 7) cell line. This was in turn established by tracing the involvement of Ca2+ ion with the CAMKIIα protein- a key player in the Ca2+/Calmodulin pathway which remains overexpressed in human colon cancer cell. CAMKIIα regulates the reactive oxygen species (ROS) production by decreasing the activity of superoxide dismutase (SOD) enzyme and hence SOD activity was also evaluated in our study. The results exhibit significant involvement of the bare, phase pure CaAl LDH at cellular level to down regulate CAMKIIα and SOD gene and its active involvement in apoptosis could also be traced.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Magnesium Oxide Properties and Applications · Vanadium and Halogenation Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (27)

Show source-provided references
1. Synthesis and characterization of Layered double Hydroxides and their potential as nonviral gene delivery vehicles
2. Ca2+-permeable channels in the hepatocyte plasma membrane and their roles in hepatocyte physiology10.1016/j.bbamcr.2008.01.016 ↗
3. Ion channels and apoptosis in cancer10.1098/rstb.2013.0104 ↗
4. The IC(50) concept revisited10.2174/156802612800672844 ↗
5. Calcium – a universal carrier of biological signals10.1111/j.1742-4658.2005.04546.x ↗
6. Bioceramics: a New Era10.1080/0371750X.2005.11012210 ↗
7. Layered double hydroxides based ceramic nanocapsules as reservoir and carrier of functional anions10.1080/0371750X.2010.11090832 ↗
8. Mg–Al layered double hydroxide–methotrexate nanohybrid drug delivery system: evaluation of efficacy10.1016/j.msec.2013.01.047 ↗
9. Methotrexate intercalated CaAl layered double hydroxide nanohybrid for drug delivery10.1166/asem.2016.1873 ↗
10. One-pot synthesis of CaAl-layered double hydroxide–methotrexate nanohybrid for anticancer application10.1007/s12034-017-1468-z ↗
11. Anionic clay as the drug delivery vehicle: tumor targeting function of layered double hydroxide-methotrexate nanohybrid in C33A orthotopic cervical cancer model10.2147/IJN.S95611 ↗
12. Calcium Signaling10.1016/j.cell.2007.11.028 ↗
13. Energetics of calmodulin domain interactions with the calmodulin binding domain of CaMKII10.1002/prot.22317 ↗
14. Anticancer Drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatment
15. Polymer coated CaAl-layered double hydroxide nanomaterials for potential calcium supplement.10.3390/ijms151222563 ↗
16. Layered double hydroxide nanocomposite for drug delivery systems; bio-distribution, toxicity and drug activity enhancement10.1186/s13065-014-0047-2 ↗
17. Removal of silver nanoparticles with native and magnetically modified halloysite
18. Regulation of Superoxide Dismutase Genes: Implications in Diseases10.1016/j.freeradbiomed.2009.05.018 ↗
19. Intracellular calcium signals and control of cell proliferation: how many mechanisms?10.1111/j.1582-4934.2004.tb00271.x ↗
20. pH dependent chemical stability and release of methotrexate from a novel nanoceramic carrier10.1039/C5RA03546E ↗
21. pH-dependent facile synthesis of CaAl-layered double hydroxides and its effect on the growth inhibition of cancer cells10.1111/jace.15555 ↗
22. The cell cycle: a new entry in the field of Ca2+ signalling10.1007/s00018-005-5083-6 ↗
23. Decoding calcium signals by multifunctional CaM kinase10.1016/0143-4160(92)90053-U ↗
24. Controlled drug delivery vehicles for cancer treatment and their performance
25. The emerging role of CaMKII in cancer10.18632/oncotarget.3955 ↗
26. A mechanism for the inactivation of Ca2+/calmodulin-dependent protein kinase II during prolonged seizure activity and its consequence after the recovery from seizure activity in rats in vivo10.1016/j.neuroscience.2006.02.054 ↗
27. Zhou · 2014 · Vol. 122 · 1